SurViva is a Norwegian consultancy providing quality guidance for life science companies.
New Norwegian research in polygenic risk score
What is the government’s ambition for the health industry?
Smaller patient groups and targeted treatments are the future of cancer care in Norway. It is no longer a question of if but when personalised medicine will be a reality for all cancer patients in Norway. This was a key message in a recent meeting arranged by the public-private consortium CONNECT during Arendalsuka, where the […]
How will Norway implement the Mission on Cancer?
Møt oss i Arendal! Vi snakker om kreftinnovasjon med politikerne.